In-vitro Colorectal Cancer Screening Tests Market

In-vitro Colorectal Cancer Screening Tests Market (Test Type: Fecal DNA Test Kits, Fecal immunochemical Test (FIT), Guaiac Fecal Occult Blood Test (gFOBT) Kits, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

In-vitro Colorectal Cancer Screening Tests Market Outlook 2034

  • The global industry was valued at US$ 1.2 Bn in 2023
  • It is projected to grow at a CAGR of 7.1% from 2023 to 2034 and reach more than US$ 2.5 Bn by the end of 2034

Analysts’ Viewpoint

Colon cancer, which is caused by cancer of the colon and rectum, ranks third in worldwide mortality charts according to the World Health Organization (WHO).

The high levels of colon cancer are associated with lifestyle factors such as overconsumption of processed meats, low fruit & vegetable intake, lack of physical activity, obesity, cigarette smoking, and excessive alcohol consumption.

Tests such as fecal immunochemical tests (FIT) are critical in assessing the chances of colon cancer for an individual. Patient screening, diagnosis, and treatment markets are dominated by hospitals and clinics due to their central role.

As awareness about colon cancer screening increases and screening programs become more widespread, the demand for these tests in hospitals and clinics is expected to rise, further strengthening their dominance in the global In-vitro Colorectal Cancer Screening Tests market.

Market Introduction

Colorectal cancer is a type of cancer that affects the colon or rectum, accounting for approximately 10% of all cancer cases. The incidence of colorectal cancer has been declining in high-income countries, thanks mainly to effective screening programs.

Fecal immunochemical test (FIT) detects hidden blood in stool from the lower intestine. It is recommended that this test should be done annually. It can be done in the privacy of the home.

Colorectal cancer and polyp cells often have DNA mutations (changes) in certain genes. Cells with these mutations are frequently shed in the stool and may be detectable by a test. Cologuard, the only test currently available in the U.S., tests for both DNA changes and blood in stool (FIT).

Attribute Detail
Drivers
  • Surge in Prevalence of Colorectal Cancer Cases

Surge in Prevalence of Colorectal Cancer Cases Boosting Market Development

In-vitro colon cancer screening tests provide a convenient, non-invasive method to detect biomarkers associated with colon cancer in biological samples such as blood and stool. These tests provide medical professionals with valuable insight into a patient's risk of developing colon cancer, allowing for timely intervention and treatment.

Colon cancer is often diagnosed at an advanced stage, leaving limited treatment options. The incidence and impact of colon cancer can be significantly reduced by implementing primary prevention strategies such as adopting a healthy lifestyle, avoiding risk factors, and early detection through screening.

Thus, the surge in number of colon cancer screening tests is expected to propel the in-vitro colorectal cancer screening tests market growth during the forecast period.

High Demand for Fecal Immunochemical Tests (FIT)

The in-vitro colorectal cancer screening tests market segmentation based on test type includes fecal DNA test kits, fecal immunochemical test (FIT), Guaiac Fecal Occult Blood Test (gFOBT) kits, and others. The fecal immunochemical test (FIT) segment dominates the market. FIT positivity reported by different screening programs may also reflect many risk factors.

An advantage of FIT is that some brands of FIT can provide quantitative Hb results; however, most countries using FIT for CRC population screening only report qualitative test results, even when quantitative tests are used.

FIT could potentially be used effectively in symptomatic patients and high-risk populations to achieve more efficient and cost-effective use of colonoscopy.

Hospitals & Clinics Gaining Traction and Fueling Market Statistics

Based on end-user, the in-vitro colorectal cancer screening tests market report reveals that the hospitals & clinics segment is currently dominating, driven by several key factors.

Hospitals and clinics act as the primary point of contact for patients seeking colon cancer screening, diagnosis, and treatment. These facilities typically have the necessary infrastructure, resources, and qualified medical professionals to effectively perform in-vitro screening tests.

Additionally, hospitals and clinics often receive referrals from general practitioners and other healthcare providers, further increasing their importance in this market segment.

Regional Outlook of In-vitro Colorectal Cancer Screening Tests Market

Attribute Detail
Leading Region North America

According to the in-vitro colorectal cancer screening tests industry analysis, North America is dominant in the landscape. The increase in number of colorectal cancer patients in the United States is expected to expand the in-vitro colorectal cancer screening tests market share of North America during the forecast period.

In the United States, colorectal cancer is the third leading cause of cancer deaths in men and the fourth leading cause of cancer deaths in women, but when both men and women are combined, it is the second leading cause of cancer deaths.

The American Cancer Society estimates that there will be approximately 106,590 new cases of colon cancer and 46,220 new cases of rectal cancer in the United States in 2024.

Furthermore, the increase in number of screening tests in Europe and Asian countries in addition to North America is expected to drive the in-vitro colon cancer screening tests market revenue.

Analysis of Key Players

According to the in-vitro colorectal cancer screening tests market report, the market is highly competitive and has a strong presence of key players. Leading players are adopting strategies such as development of products and collaborative partnerships.

Abbott Laboratories, Thermofisher Scientific Inc., Eiken Chemical Co., Ltd, Qiagen, Quest Diagnostics Incorporated, Sentinel CH. SpA, Quidel Corporation, Freenome Holdings, Inc., Immunostics, Inc., and BTNX, Inc. are the prominent In-vitro colorectal cancer screening tests market manufacturers profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In November 2023, Guardant Health, Inc., a leading precision oncology business, announced the introduction of ShieldTM, a blood-based colorectal cancer screening test, in conjunction with Samsung Medical Centre in South Korea.
  • In November 2023, Geneoscopy, a life sciences business that develops diagnostic tests for gastrointestinal health, announced a multi-year cooperation with Labcorp to expand access to the firm's next-generation colon cancer screening test.

In-vitro Colorectal Cancer Screening Tests Market Snapshot

Attribute Detail
Market Value in 2023 US$ 1.2 Bn
Forecast (Value) in 2034 US$ 2.5 Bn
Growth Rate (CAGR) 7.1%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn for Value
Market Analysis It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Test Type
    • Fecal DNA Test Kits
    • Fecal immunochemical test (FIT)
    • Guaiac Fecal Occult Blood Test (gFOBT) Kits
    • Others
  • End-user
    • Hospitals & Clinics
    • Diagnostic Centers
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • Abbott Laboratories
  • Thermofisher Scientific Inc.
  • Eiken Chemical Co., Ltd
  • Qiagen
  • Quest Diagnostics Incorporated
  • Sentinel CH. SpA
  • Quidel Corporation
  • Freenome Holdings, Inc.
  • Immunostics, Inc.
  • BTNX, Inc.
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global in-vitro colorectal cancer screening tests market in 2023?

It was valued at US$ 1.2 Bn in 2023

How big will the in-vitro colorectal cancer screening tests industry be by 2034?

It is projected to reach more than US$ 2.5 Bn by the end of 2034

What will be the CAGR of the in-vitro colorectal cancer screening tests business during the forecast period?

The CAGR is anticipated to be 7.1% from 2024 to 2034

What are the prominent factors fueling demand for in-vitro colorectal cancer screening tests?

Surge in prevalence of colorectal cancer

Which was the largest in-vitro colorectal cancer screening tests segment in 2023?

Based on test type, the fecal immunochemical test (FIT) segment accounted for major share in 2023

Which region is likely to record significant share of the in-vitro colorectal cancer screening tests sector during the forecast period?

North America is expected to account for major share during the forecast period

Who are the prominent in-vitro colorectal cancer screening tests manufacturers?

Abbott Laboratories, Thermofisher Scientific Inc., Eiken Chemical Co., Ltd, Qiagen, Quest Diagnostics Incorporated, Sentinel CH. SpA, Quidel Corporation, Freenome Holdings, Inc., Immunostics, Inc., and BTNX, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global In-vitro Colorectal Cancer Screening Tests Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, 2020-2034

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Porter’s Five Force Analysis

        5.2. Key Industry Events

        5.3. Prevalence of Cancer

    6. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Test Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Test Type, 2020-2034

            6.3.1. Fecal DNA Test Kits

            6.3.2. Fecal immunochemical Test (FIT)

            6.3.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits

            6.3.4. Others

        6.4. Market Attractiveness By Test Type

    7. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By End-user, 2020-2034

            7.3.1. Hospitals & Clinics

            7.3.2. Diagnostic Centers

            7.3.3. Others

        7.4. Market Attractiveness By End-user

    8. Global In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecasts, By Region

        8.1. Key Findings

        8.2. Market Value Forecast By Region

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness By Country/Region

    9. North America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Market Value Forecast By Test Type, 2020-2034

            9.2.1. Fecal DNA Test Kits

            9.2.2. Fecal immunochemical Test (FIT)

            9.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits

            9.2.4. Others

        9.3. Market Value Forecast By End-user, 2020-2034

            9.3.1. Hospitals & Clinics

            9.3.2. Diagnostic Centers

            9.3.3. Others

        9.4. Market Value Forecast By Country, 2020-2034

            9.4.1. U.S.

            9.4.2. Canada

        9.5. Market Attractiveness Analysis

            9.5.1. By Test Type

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast By Test Type, 2020-2034

            10.2.1. Fecal DNA Test Kits

            10.2.2. Fecal immunochemical Test (FIT)

            10.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits

            10.2.4. Others

        10.3. Market Value Forecast By End-user, 2020-2034

            10.3.1. Hospitals & Clinics

            10.3.2. Diagnostic Centers

            10.3.3. Others

        10.4. Market Value Forecast By Country, 2020-2034

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Italy

            10.4.5. Spain

            10.4.6. Rest of Europe

        10.5. Market Attractiveness Analysis

            10.5.1. By Test Type

            10.5.2. By End-user

            10.5.3. By Country

    11. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Test Type, 2020-2034

            11.2.1. Fecal DNA Test Kits

            11.2.2. Fecal immunochemical Test (FIT)

            11.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits

            11.2.4. Others

        11.3. Market Value Forecast By End-user, 2020-2034

            11.3.1. Hospitals & Clinics

            11.3.2. Diagnostic Centers

            11.3.3. Others

        11.4. Market Value Forecast By Country, 2020-2034

            11.4.1. China

            11.4.2. India

            11.4.3. Japan

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Market Attractiveness Analysis

            11.5.1. By Test Type

            11.5.2. By End-user

            11.5.3. By Country

    12. Latin America In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Test Type, 2020-2034

            12.2.1. Fecal DNA Test Kits

            12.2.2. Fecal immunochemical Test (FIT)

            12.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits

            12.2.4. Others

        12.3. Market Value Forecast By End-user, 2020-2034

            12.3.1. Hospitals & Clinics

            12.3.2. Diagnostic Centers

            12.3.3. Others

        12.4. Market Value Forecast By Country, 2020-2034

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Market Attractiveness Analysis

            12.5.1. By Test Type

            12.5.2. By End-user

            12.5.3. By Country

    13. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Test Type, 2020-2034

            13.2.1. Fecal DNA Test Kits

            13.2.2. Fecal immunochemical Test (FIT)

            13.2.3. Guaiac Fecal Occult Blood Test (gFOBT) Kits

            13.2.4. Others

        13.3. Market Value Forecast By End-user, 2020-2034

            13.3.1. Hospitals & Clinics

            13.3.2. Diagnostic Centers

            13.3.3. Others

        13.4. Market Value Forecast By Country, 2020-2034

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Market Attractiveness Analysis

            13.5.1. By Test Type

            13.5.2. By End-user

            13.5.3. By Country

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (By Tier and Size of companies)

        14.2. Market Share Analysis By Company (2023)

        14.3. Company Profiles

            14.3.1. Abbott Laboratories

                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. Financial Overview

                14.3.1.4. SWOT Analysis

                14.3.1.5. Strategic Overview

            14.3.2. Thermofisher Scientific Inc.

                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. Financial Overview

                14.3.2.4. SWOT Analysis

                14.3.2.5. Strategic Overview

            14.3.3. Eiken Chemical Co., Ltd

                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. Financial Overview

                14.3.3.4. SWOT Analysis

                14.3.3.5. Strategic Overview

            14.3.4. Qiagen

                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. Financial Overview

                14.3.4.4. SWOT Analysis

                14.3.4.5. Strategic Overview

            14.3.5. Quest Diagnostics Incorporated

                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Product Portfolio

                14.3.5.3. Financial Overview

                14.3.5.4. SWOT Analysis

                14.3.5.5. Strategic Overview

            14.3.6. Sentinel CH. SpA

                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Product Portfolio

                14.3.6.3. Financial Overview

                14.3.6.4. SWOT Analysis

                14.3.6.5. Strategic Overview

            14.3.7. Quidel Corporation

                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Product Portfolio

                14.3.7.3. Financial Overview

                14.3.7.4. SWOT Analysis

                14.3.7.5. Strategic Overview

            14.3.8. Freenome Holdings, Inc.

                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Product Portfolio

                14.3.8.3. Financial Overview

                14.3.8.4. SWOT Analysis

            14.3.9. Immunostics, Inc.

                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.9.2. Product Portfolio

                14.3.9.3. Financial Overview

                14.3.9.4. SWOT Analysis

            14.3.10. BTNX, Inc.

                14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.3.10.2. Product Portfolio

                14.3.10.3. Financial Overview

                14.3.10.4. SWOT Analysis

    List of Tables

    Table 01: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 02: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 03: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Region, 2020-2034

    Table 04: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country, 2020-2034

    Table 05: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 06: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 07: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 08: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 09: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by End-user, 2020-2034

    Table 10: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 11: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 12: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 13: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 14: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Test Type, 2020-2034

    Table 15: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 16: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 17: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    Table 18: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

    List of Figures

    Figure 01: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast, 2017-2031

    Figure 02: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 03: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Test Type, 2023

    Figure 04: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Test Type, 2034

    Figure 05: Global In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 06: Global In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 07: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by End-user, 2023

    Figure 08: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by End-user, 2034

    Figure 09: Global In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 10: Global In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Region, 2023 and 2034

    Figure 11: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Region, 2023

    Figure 12: Global In-vitro Colorectal Cancer Screening Tests Market Share Analysis, by Region, 2034

    Figure 13: Global In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Region, 2023-2034

    Figure 14: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 15: North America In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country, 2023 and 2034

    Figure 16: North America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country, 2024-2034

    Figure 17: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 18: North America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 19: North America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 20: North America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 21: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 22: Europe In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 23: Europe In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

    Figure 24: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 25: Europe In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 26: Europe In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 27: Europe In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 28: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 29: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 30: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

    Figure 31: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 32: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 33: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 34: Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 35: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 36: Latin America In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 37: Latin America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

    Figure 38: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 39: Latin America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 40: Latin America In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 41: Latin America In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034

    Figure 42: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

    Figure 43: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

    Figure 44: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

    Figure 45: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by Test Type, 2023 and 2034

    Figure 46: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by Test Type, 2024-2034

    Figure 47: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034

    Figure 48: Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Attractiveness Analysis, by End-user, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved